Urovant Sciences Ltd.
UROV
UROV was delisted on the 26th of March, 2021.
23 hedge funds and large institutions have $54.2M invested in Urovant Sciences Ltd. in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 5 closing their positions.
8% less funds holding
Funds holding: 25 → 23 (-2)
13% less capital invested
Capital invested by funds: $62.4M → $54.2M (-$8.21M)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$330K |
| 2 |
PHS
Pekin Hardy Strauss
Chicago,
Illinois
|
+$329K |
| 3 |
MWNA
Marshall Wace North America
New York
|
+$240K |
| 4 |
VWM
Vigilare Wealth Management
Scottsdale,
Arizona
|
+$24.9K |
| 5 |
CFGS
Concourse Financial Group Securities
Birmingham,
Alabama
|
+$11.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$2.12M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.28M |
| 3 |
BBVA
Banco Bilbao Vizcaya Argentaria
Madrid,
Spain
|
-$1M |
| 4 |
Renaissance Technologies
New York
|
-$460K |
| 5 |
Millennium Management
New York
|
-$340K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | +$27 | +3 | New |
|
27
JP Morgan Chase
New York
| – | +$62 | +7 | New |
|
UROV Hedge Fund Activity: Q3 2020 in Review
23 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Urovant Sciences Ltd. (UROV) for Q3 2020, worth a combined $54.2M — down 13% from $62.4M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of UROV and 3 opened new positions — a net loss of 2 holders — while 7 trimmed existing stakes and 4 added.
The largest buyer was Wells Fargo, adding an estimated $330K. The largest seller was BlackRock, cutting an estimated $2.12M.
- 23 institutional investors held Urovant Sciences Ltd. (UROV) as of Q3 2020, down from 25 in Q2 2020.
- Funds reported $54.2M of Urovant Sciences Ltd. stock for Q3 2020, down 13% quarter-over-quarter.
- 3 funds opened new Urovant Sciences Ltd. positions in Q3 2020 and 5 closed out, a net change of -2 holders.
- The largest Urovant Sciences Ltd. buyer in Q3 2020 was Wells Fargo, an estimated $330K added.
- The largest Urovant Sciences Ltd. seller in Q3 2020 was BlackRock, an estimated $2.12M sold.
Based on aggregated 13F filings for Q3 2020.